Cargando…
Development of a distributed international patient data registry for hairy cell leukemia
Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder, comprising only 2% of all leukemias. The Hairy Cell Leukemia Foundation (HCLF) has developed a patient data registry to enable investigators to better study the clinical features, treatment outcomes, and complications of patients with...
Ejemplares similares
-
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
por: Ravandi, Farhad, et al.
Publicado: (2022) -
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
por: Grever, Michael, et al.
Publicado: (2021) -
Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant
por: Liu, Qiuying, et al.
Publicado: (2021) -
Single‐center study of outcomes of patients with hairy cell leukemia who contracted SARS‐CoV‐2
por: Annunzio, Kaitlin, et al.
Publicado: (2023) -
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021)